Le Lézard
Classified in: Health, Business
Subjects: CXP, MAT

Vireo Health Completes Capacity Expansion Projects in Maryland and Receives Approval to Open First Retail Dispensary in the State


MINNEAPOLIS, Feb. 26, 2021 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), the science-focused, multi-state cannabis company, today announced that its subsidiary company, MaryMed, LLC, has completed its previously-announced capacity expansion initiatives in the state of Maryland and has also received regulatory approval to open its first retail dispensary in Maryland, located in the town of Frederick.

"We are very pleased to complete our vertical integration in Maryland, where the state's medical cannabis program is continuing to experience increasing demand and there is potential for the passage of adult use legislation this session," said Chairman and Chief Executive Officer, Dr. Kyle Kingsley. "The recent investments we've made to expand cultivation and processing capabilities and the opening of our first retail location will help us meet growing demand for cannabis products in the state for the foreseeable future."

The completion of MaryMed's capacity expansion was achieved earlier this week when the Company transferred the cultivation operations of its former 22,500 sq. ft. co-located cultivation and processing facility in Hurlock, MD to its new 110,000 sq. ft. location in Massey, MD, which also received regulatory approval this week. The cultivation facility in Massey is already operational and is expected to increase the Company's cultivation capacity in the state by nearly 12 times. The facility in Hurlock will now be used solely for processing and manufacturing finished products to be sold to wholesale and retail customers.  The expanded processing space will accommodate the implementation of several more manufacturing lines.

The Company's Green Goodstm retail dispensary in Frederick is expected to open on March 12, 2021. Green Goodstm locations are designed to create an inviting atmosphere that provides personalized service and wellness programs for cannabis consumers. The Frederick location will be the Company's first dispensary in Maryland and 16th dispensary nationwide. Vireo's management team expects to continue pursuing additional opportunities to improve revenue growth and profitability in the state of Maryland.

About Vireo Health International, Inc.

Vireo Health International, Inc. is a physician-led cannabis company focused on bringing the best of technology, science, and engineering to the cannabis industry. Vireo manufactures proprietary, branded cannabis products in environmentally friendly facilities, state-of-the-art cultivation sites and distributes its products through its growing network of Green Goodstm and other retail locations and third-party dispensaries. Vireo's team of more than 400 employees, led by scientists, engineers, and cultivation experts, is focused on efficiency and the creation of best-in-class products, while driving scientific innovation within the cannabis industry and developing meaningful intellectual property. Today, Vireo is licensed to grow and/or process cannabis in eight markets and operates 15 dispensaries nationwide. Vireo holds additional retail licenses in four markets. For more information about Vireo Health, please visit www.vireohealth.com.

Forward Looking Statement Disclosure

This press release contains "forward-looking information" within the meaning of applicable United States and Canadian securities legislation. To the extent any forward-looking information in this press release constitutes "financial outlooks" within the meaning of applicable United States or Canadian securities laws, such information is being provided as preliminary financial results and the reader is cautioned that this information may not be appropriate for any other purpose and the reader should not place undue reliance on such financial outlooks. Forward-looking information contained in this press release may be identified by the use of words such as "potential," "plans," "is expected," "expects," "does not expect," "growing" or "foreseeable." Forward-looking information is based upon a number of estimates and assumptions of management, believed but not certain to be reasonable, in light of management's experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits.

Media Inquiries

Investor Inquiries

Albe Zakes

Sam Gibbons

Vice President, Corporate Communications

Vice President, Investor Relations

[email protected]    

[email protected]    

(267) 221-4800

(612) 314-8995

 

SOURCE Vireo Health International, Inc.


These press releases may also interest you

at 01:38
The Barcelona R&D Center ("the Center") of Wanhua Chemical (SHA:600309; "the Company"), located at Cornella de Llobregat, has officially opened its doors as a pivotal move by the company to advance its footprint in Europe and beyond with a quicker...

at 01:35
Regulatory News: Pernod Ricard (Paris:RI): Press Release ? Paris, 25 April 2024 This robust performance illustrates the strength of our diversified portfolio of premium international spirits and our broad-based geographic footprint covering...

at 01:30
Happiest Minds Technologies Limited (NSE: HAPPSTMNDS), a 'Born Digital. Born Agile', Mindful IT Company, today announced it signed definitive agreements to acquire 100% of the equity share capital of PureSoftware Technologies Private Limited...

at 01:21
Aker Solutions has delivered strong revenue growth and improved profitability in the first quarter of 2024 compared to the same period last year. With a solid backlog and high tendering activity, the company is well positioned for future profitable...

at 01:18
First Quarter Highlights            HMH delivered an EBITDA (adj.) of USD 33 million in quarter, about 75% increase year-over-year driven by higher aftermarket activityNES Fircroft delivered 17% increase in EBITDA and 12% revenue growth...

at 01:17
Quarter 1, 2024 - High profitability and strong cash flow Net sales decreased 4.1% to SEK 34,850m (36,352)Organic growth amounted to -4.0%, of which volume accounted for -1.8% and price/mix -2.2%. Excluding restructuring and exited contracts, volumes...



News published on and distributed by: